IDOX PLC
01 February 2006
For immediate release
1 February 2006
IDOX plc ('IDOX' or 'the Company')
Holding in Company
The Company announces that they received formal notification today that Nigel
Oxbrow is now beneficially interested in 14,610,768 ordinary shares of 1p each
in the Company representing 7.48% of the current issued share capital of the
Company. The increased holding of Nigel Oxbrow results from the issue of new
ordinary shares as earn out consideration to the vendors of TFPL Limited, as
announced on 26 January 2006. Under this agreement, both Nigel Oxbrow and Bindy
Pease, wife of Nigel Oxbrow, were issued with 3,436,196 new ordinary shares in
the Company on the basis of a price of 11.225 pence per share.
The ordinary shares referred to above are ordinary shares of 1p per share. There
are now 195,260,900 ordinary shares in issue following admission to AIM today of
the new ordinary shares under the earn out agreement.
For further information please contact:
Andrew Fraser, Chief Executive, IDOX plc Tel: 020 7954 3800
Alasdair Robinson, Noble & Company Limited Tel: 0131 225 9677
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.